New drug aims to melt liver fat in NASH patients
NCT ID NCT05842512
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a drug called ADI-PEG 20 against a placebo in 60 adults with nonalcoholic steatohepatitis (NASH), a type of fatty liver disease. Participants receive injections over 24 weeks, and doctors measure changes in liver fat using MRI. The goal is to see if the drug can safely reduce liver fat and improve the condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ADI-PEG 20 (pegargiminase)
- What this could lead to
- If it works, this could point toward a new treatment for nonalcoholic steatohepatitis (NASH), a serious fatty liver disease.
- What could go wrong
- This is an early phase 2 trial with only 60 people, so results may not be conclusive. The drug may not reduce liver fat better than placebo, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONALCOHOLIC STEATOHEPATITIS (NASH) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chang Gung Medical Foundation-Kaohsiung (CGMF-KS)
RECRUITINGKaohsiung, Taiwan, 833, Taiwan
-
Chang Gung Medical Foundation-Keelung (CGMF-KL)
RECRUITINGKeelung, Taiwan, 204, Taiwan
-
Chang Gung Medical Foundation-Linkou (CGMF-LK)
RECRUITINGTaoyuan, Taiwan, 333, Taiwan
-
Ditmanson Medical Foundation Chiayi Christian Hospital;Chiayi Christian Hospital (CYCH)
RECRUITINGChiayi City, Taiwan, 600566, Taiwan
-
E-Da Hospital (EDH)
RECRUITINGKaohsiung, Taiwan, 824, Taiwan
-
Fu Jen Catholic University Hospital (FJCUH)
RECRUITINGTaipei, Taiwan, 243, Taiwan
-
Kaohsiung Medical University Chung-Ho Memorial Hospital(KMUH)
RECRUITINGKaohsiung, Taiwan, 807, Taiwan
-
National Cheng Kung University Hospital (NCKUH)
RECRUITINGTainan, Taiwan, 704, Taiwan
-
National Taiwan University Hospital (NTUH)
RECRUITINGTaipei, Taiwan, 100229, Taiwan
-
Taipei Veterans General Hospital (TPVGH)
RECRUITINGTaipei, Taiwan, 112201, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single pill tackle both fatty liver and diabetes?
- New drug miricorilant tested for fatty liver disease safety
- New drug aramchol aims to reverse fatty liver damage in phase 3 trial
- New drug shows promise against fatty liver disease in Mid-Stage trial
- New drug aims to shrink fatty liver in early trial
- New shot shows promise for fatty liver disease in early trial